ConductScience.org, home

Paper2069366

Antibacterial activities and modes of action of vancomycin and related glycopeptides.

Nagarajan R. Antimicrob Agents Chemother, 1991. Cited by 98 papers, by iCite.

Cite this record

ConductScience Library. Antibacterial activities and modes of action of vancomycin and related glycopeptides. Papers, record 2069366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2069366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antibacterial activities and modes of action of vancomycin and related glycopeptides.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1991
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
98
iCite
Relative citation ratio, by iCite
3.5
iCite
Revised in PubMed
2021-05-26
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nagarajan RR

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriaMajor topic
GlycopeptidesMajor topic
VancomycinMajor topic
Structure-Activity Relationship

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15967114Compounds formed between nucleotides related to the biosynthesis of bacterial cell wall and vancomycin.Biochem Biophys Res Commun1966https://conductscience.org/library/papers/5967114PubMed
214324547LIPID-PHOSPHOACETYLMURAMYL-PENTAPEPTIDE AND LIPID-PHOSPHODISACCHARIDE-PENTAPEPTIDE: PRESUMED MEMBRANE TRANSPORT INTERMEDIATES IN CELL WALL SYNTHESIS.Proc Natl Acad Sci U S A1965https://conductscience.org/library/papers/14324547PubMed
36548221A51568A: N-demethylvancomycin.J Antibiot (Tokyo)1984https://conductscience.org/library/papers/6548221PubMed
46238927Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VI. Chemical degradation: physico-chemical and biological properties of acid hydrolysis products.J Antibiot (Tokyo)1984https://conductscience.org/library/papers/6238927PubMed
56240963Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6240963PubMed
62869019Aridicins, novel glycopeptide antibiotics. III. Preparation, characterization, and biological activities of aglycone derivatives.J Antibiot (Tokyo)1986https://conductscience.org/library/papers/2869019PubMed
72942100Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/2942100PubMed
83781910Kibdelins (AAD-609), novel glycopeptide antibiotics. II. Isolation, purification and structure.J Antibiot (Tokyo)1986https://conductscience.org/library/papers/3781910PubMed
93624076Parvodicin, a novel glycopeptide from a new species, Actinomadura parvosata: discovery, taxonomy, activity and structure elucidation.J Antibiot (Tokyo)1987https://conductscience.org/library/papers/3624076PubMed
102891921Vancomycin-resistant enterococci.Lancet1988https://conductscience.org/library/papers/2891921PubMed
113403380New glycopeptide antibiotics. I. The structures of orienticins.J Antibiot (Tokyo)1988https://conductscience.org/library/papers/3403380PubMed
123192496Synthesis and antibacterial activity of N-acyl vancomycins.J Antibiot (Tokyo)1988https://conductscience.org/library/papers/3192496PubMed
133272137New glycopeptide antibiotics: II. The isolation and structures of chloroorienticins.J Antibiot (Tokyo)1988https://conductscience.org/library/papers/3272137PubMed
142921228Synthesis and antibacterial evaluation of N-alkyl vancomycins.J Antibiot (Tokyo)1989https://conductscience.org/library/papers/2921228PubMed
152817848Activity of glycopeptides against vancomycin-resistant gram-positive bacteria.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2817848PubMed
162532132Structure, biochemistry and mechanism of action of glycopeptide antibiotics.Eur J Clin Microbiol Infect Dis1989https://conductscience.org/library/papers/2532132PubMed
172113517MM 45289, a potent glycopeptide antibiotic which interacts weakly with diacetyl-L-lysyl-D-alanyl-D-alanine.J Antibiot (Tokyo)1990https://conductscience.org/library/papers/2113517PubMed
1914287259STRUCTURE STUDIES ON VANCOMYCIN.J Med Chem1965https://conductscience.org/library/papers/14287259PubMed
206027793Biosythesis of the peptidoglycan of bacterial cell walls. II. Phospholipid carriers in the reaction sequence.J Biol Chem1967https://conductscience.org/library/papers/6027793PubMed

Download CSV of references

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.

PMIDTitleJournalYearIn PapersSource
41961464Chitooligosaccharide-based hydrogel microneedle for the effective transdermal delivery of vancomycin.Drug Deliv Transl Res2026https://conductscience.org/library/papers/41961464PubMed
41161584The antiarrhythmic drugs dronedarone and amiodarone exhibit potent in vitro and in vivo activity against Clostridioides difficile.Int J Antimicrob Agents2026https://conductscience.org/library/papers/41161584PubMed
40757024Pharmacotherapy variability and precision medicine in neurocritical care.Front Neurol2025https://conductscience.org/library/papers/40757024PubMed
40666031Fluorescent Antibiotics: Bridging Diagnostic and Therapy in the Fight against Bacterial Infections.Small Sci2025https://conductscience.org/library/papers/40666031PubMed
39902442Hypothesizing Protocol for Soft Tissue Rejuvenation of Comminuted Maxillofacial Fractures with Glycopeptide Antibiotic.J Maxillofac Oral Surg2025https://conductscience.org/library/papers/39902442PubMed
39600109Vancomycin population pharmacokinetic models: Uncovering pharmacodynamic divergence amid clinicobiological resemblance.CPT Pharmacometrics Syst Pharmacol2025https://conductscience.org/library/papers/39600109PubMed
38578803Comparison of qPCR and metagenomic sequencing methods for quantifying antibiotic resistance genes in wastewater.PLoS One2024https://conductscience.org/library/papers/38578803PubMed
38560705Inhibiting Peptidoglycan Hydrolase Alleviates MRSA Pneumonia Through Autolysin-Mediated MDP-NOD2 Pathway.Infect Drug Resist2024https://conductscience.org/library/papers/38560705PubMed
37093913Analysis of antibiotic resistance genes in pig feces during the weaning transition using whole metagenome shotgun sequencing.J Anim Sci Technol2023https://conductscience.org/library/papers/37093913PubMed
36134162Staphylococcus aureus entanglement in self-assembling β-peptide nanofibres decorated with vancomycin.Nanoscale Adv2021https://conductscience.org/library/papers/36134162PubMed
35675307Staphylococcus aureus cell wall maintenance - the multifaceted roles of peptidoglycan hydrolases in bacterial growth, fitness, and virulence.FEMS Microbiol Rev2022https://conductscience.org/library/papers/35675307PubMed
35539660Diaryl ethers synthesis: nano-catalysts in carbon-oxygen cross-coupling reactions.RSC Adv2018https://conductscience.org/library/papers/35539660PubMed
35126378Effect of D-Ala-Ended Peptidoglycan Precursors on the Immune Regulation of Lactobacillus plantarum Strains.Front Immunol2021https://conductscience.org/library/papers/35126378PubMed
34834215Development of Novel Peptides for the Antimicrobial Combination Therapy against Carbapenem-Resistant Acinetobacter baumannii Infection.Pharmaceutics2021https://conductscience.org/library/papers/34834215PubMed
34697316Antibiotic-chemoattractants enhance neutrophil clearance of Staphylococcus aureus.Nat Commun2021https://conductscience.org/library/papers/34697316PubMed
32269153First Report of the Local Spread of Vancomycin-Resistant Enterococci Ascribed to the Interspecies Transmission of a vanA Gene Cluster-Carrying Linear Plasmid.mSphere2020https://conductscience.org/library/papers/32269153PubMed
24236721Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.Curr Top Med Chem2014https://conductscience.org/library/papers/24236721PubMed
23028676mMass as a software tool for the annotation of cyclic peptide tandem mass spectra.PLoS One2012https://conductscience.org/library/papers/23028676PubMed
22514280Lipodepsipeptide empedopeptin inhibits cell wall biosynthesis through Ca2+-dependent complex formation with peptidoglycan precursors.J Biol Chem2012https://conductscience.org/library/papers/22514280PubMed
22314525Product quality of parenteral vancomycin products in the United States.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22314525PubMed

See all 36 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2069366

GET https://conductscience.org/api/papers/v1/2069366/cited_by?page=2